4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-20-000284
Director sold 1,000 shares at an average $396.82 ($396,819)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FOLETTA MARK G Director | 2020-10-15 | Sale | −42 | $391.48 | $16,442 | 15,160 | I: show line 1 in the form |
| FOLETTA MARK G Director | 2020-10-15 | Sale | −120 | $395.02 | $47,402 | 15,040 | I: show line 2 in the form |
| FOLETTA MARK G Director | 2020-10-15 | Sale | −255 | $396.51 | $101,109 | 14,785 | I: show line 3 in the form |
| FOLETTA MARK G Director | 2020-10-15 | Sale | −375 | $397.41 | $149,030 | 14,410 | I: show line 4 in the form |
| FOLETTA MARK G Director | 2020-10-15 | Sale | −208 | $398.25 | $82,835 | 14,202 | I: show line 5 in the form |
| Open-market sales · 1,000 sh · avg $396.82 · $396,819 | |||||||
Loading xslF345X03/edgardoc.xml…